Dextromethorphan and memantine after ketamine analgesia: a randomized control trial

References

• van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662. doi:10.1016/j.pain.2013.11.01324291734
   PubMed Web of Science ®Google Scholar
• Deng Y, Luo L, Hu Y, Fang K, Liu J. Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC Anesthesiol. 2016;16:12. doi:10.1186/s12871-015-0150-526892406
   PubMed Web of Science ®Google Scholar
• Zhou H-Y, Chen S-R, Pan H-L. Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain. Expert Rev Clin Pharmacol. 2011;4(3):379–388.21686074
   PubMedGoogle Scholar
• Carlsson KC, Hoem NO, Moberg ER, Mathisen LC. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand. 2004;48(3):328–336. doi:10.1111/j.0001-5172.2004.0325.x14982566
   PubMed Web of Science ®Google Scholar
• Ehret GB, Daali Y, Chabert J, et al. Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain. Pain Physician. 2013;16(1):45–56.23340533
   PubMed Web of Science ®Google Scholar
• Jørum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine–a double-blind, cross-over comparison with alfentanil and placebo. Pain. 2003;101(3):229–235.12583865
   PubMed Web of Science ®Google Scholar
• Morel V, Joly D, Villatte C, et al. Memantine before mastectomy prevents post-surgery pain: a randomized, blinded clinical trial in surgical patients. PLoS One. 2016;11(4):e0152741. doi:10.1371/journal.pone.015274127050431
   PubMed Web of Science ®Google Scholar
• Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology. 2002;96(5):1053–1061.11981142
   PubMed Web of Science ®Google Scholar
• Himmelseher S, Durieux ME. Ketamine for perioperative pain management. Anesthesiology. 2005;102(1):211–220.15618805
   PubMed Web of Science ®Google Scholar
• Shanthanna H, Huilgol M, Manivackam VK. Early and effective use of ketamine for treatment of phantom limb pain. Indian J Anaesth. 2010;54(2):157–159. doi:10.4103/0019-5049.6363220661356
   PubMedGoogle Scholar
• Dualé C, Sibaud F, Guastella V, et al. Perioperative ketamine does not prevent chronic pain after thoracotomy. Eur J Pain Lond Engl. 2009;13(5):497–505. doi:10.1016/j.ejpain.2008.06.013
   PubMed Web of Science ®Google Scholar
• Mendola C, Cammarota G, Netto R, et al. S+ -ketamine for control of perioperative pain and prevention of post thoracotomy pain syndrome: a randomized, double-blind study. Minerva Anestesiol. 2012;78(7):757–766.22441361
   PubMed Web of Science ®Google Scholar
• Jackson K, Ashby M, Martin P, Pisasale M, Brumley D, Hayes B. “Burst” ketamine for refractory cancer pain: an open-label audit of 39 patients. J Pain Symptom Manage. 2001;22(4):834–842. doi:10.1016/S0885-3924(01)00340-211576800
   PubMed Web of Science ®Google Scholar
• Rabben T, Skjelbred P, Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 1999;289(2):1060–1066.10215688
   PubMed Web of Science ®Google Scholar
• Patil S, Anitescu M. Efficacy of outpatient ketamine infusions in refractory chronic pain syndromes: a 5-year retrospective analysis. Pain Med Malden Mass. 2012;13(2):263–269. doi:10.1111/j.1526-4637.2011.01241.x
   PubMed Web of Science ®Google Scholar
• Dahan A, Olofsen E, Sigtermans M, et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain Lond Engl. 2011;15(3):258–267. doi:10.1016/j.ejpain.2010.06.016
   PubMed Web of Science ®Google Scholar
• Sigtermans MJ, van Hilten JJ, Bauer MCR, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. PAIN. 2009;145(3):304–311. doi:10.1016/j.pain.2009.06.02319604642
   PubMed Web of Science ®Google Scholar
• Cvrcek P. Side effects of ketamine in the long-term treatment of neuropathic pain. Pain Med Malden Mass. 2008;9(2):253–257. doi:10.1111/j.1526-4637.2007.00314.x
   PubMed Web of Science ®Google Scholar
• Schley M, Topfner S, Wiech K, et al. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees. Eur J Pain. 2007;11(3):299–308. doi:10.1016/j.ejpain.2006.03.00316716615
   PubMed Web of Science ®Google Scholar
• Eisenberg K, Dortort H, Yarnitsky D. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. Eur J Pain Lond Engl. 1998;2(4):321–327. doi:10.1016/S1090-3801(98)90030-1
   PubMed Web of Science ®Google Scholar
• Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997;48(5):1212–1218. doi:10.1212/wnl.48.5.12129153445
   PubMed Web of Science ®Google Scholar
• Shaibani AI, Pope LE, Thisted R, Hepner A. Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study. Pain Med Malden Mass. 2012;13(2):243–254. doi:10.1111/j.1526-4637.2011.01316.x
   PubMed Web of Science ®Google Scholar
• Heiskanen T, Härtel B, Dahl M-L, Seppälä T, Kalso E. Analgesic effects of dextromethorphan and morphine in patients with chronic pain. Pain. 2002;96(3):261–267.11972998
   PubMed Web of Science ®Google Scholar
• Noetzli M, Guidi M, Ebbing K, et al. Population pharmacokinetic study of memantine: effects of clinical and genetic factors. Clin Pharmacokinet. 2013;52(3):211–223. doi:10.1007/s40262-013-0032-223371894
   PubMed Web of Science ®Google Scholar
• Pickering G, Pereira B, Morel V, et al. Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients. Contemp Clin Trials. 2014;38(2):314–320. doi:10.1016/j.cct.2014.06.00424948402
   PubMed Web of Science ®Google Scholar
• Sachse C, Brockmöller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet. 1997;60(2):284–295.9012401
   PubMed Web of Science ®Google Scholar
• Johansson I, Lundqvist E, Dahl ML, Ingelman-Sundberg M. PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics. 1996;6(4):351–355.8873221
   PubMedGoogle Scholar
• Brambila-Tapia AJ-L. MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. Rev Investig Clínica Organo Hosp Enfermedades Nutr. 2013;65(5):445–454.
   PubMedGoogle Scholar
• Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol Camb Mass. 1990;1(1):43–46. doi:10.1097/00001648-199001000-00010
   PubMedGoogle Scholar
• Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8. doi:10.1186/1471-2288-2-812069695
   PubMedGoogle Scholar
• Rubiś B, Hołysz H, Barczak W, et al. Study of ABCB1 polymorphism frequency in breast cancer patients from Poland. Pharmacol Rep PR. 2012;64(6):1560–1566.23406767
   PubMed Web of Science ®Google Scholar
• Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addict Biol. 2005;10(4):325–327. doi:10.1080/1355621050035241016318953
   PubMed Web of Science ®Google Scholar
• Nguyen L, Robson MJ, Healy JR, Scandinaro AL, Matsumoto RR. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. Siegel A, ed. PLoS One. 2014;9(2):e89985. doi:10.1371/journal.pone.008998524587167
   PubMed Web of Science ®Google Scholar
• Apkarian AV, Sosa Y, Krauss BR, et al. Chronic pain patients are impaired on an emotional decision-making task. Pain. 2004;108(1–2):129–136. doi:10.1016/j.pain.2003.12.01515109516
   PubMed Web of Science ®Google Scholar
• Zarate CA, Singh JB, Quiroz JA, et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry. 2006;163(1):153–155. doi:10.1176/appi.ajp.163.1.15316390905
   PubMed Web of Science ®Google Scholar
• Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. 2014;77(2):357–367. doi:10.1111/bcp.1209423432384
   PubMed Web of Science ®Google Scholar
• Desta Z, Moaddel R, Ogburn ET, et al. Stereoselective and regiospecific hydroxylation of ketamine and norketamine. Xenobiotica Fate Foreign Compd Biol Syst. 2012;42(11):1076–1087. doi:10.3109/00498254.2012.685777
   PubMed Web of Science ®Google Scholar
• Moaddel R, Abdrakhmanova G, Kozak J, et al. Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors. Eur J Pharmacol. 2013;698(1–3):228–234. doi:10.1016/j.ejphar.2012.11.02323183107
   PubMed Web of Science ®Google Scholar
• Zhao X, Venkata SLV, Moaddel R, et al. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. Br J Clin Pharmacol. 2012;74(2):304–314. doi:10.1111/j.1365-2125.2012.04198.x22295895
   PubMed Web of Science ®Google Scholar
• Schüttler J, Stanski DR, White PF, et al. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet Biopharm. 1987;15(3):241–253.3668802
   PubMedGoogle Scholar
• Sigtermans M, Dahan A, Mooren R, et al. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology. 2009;111(4):892–903. doi:10.1097/ALN.0b013e3181b437b119741495
   PubMed Web of Science ®Google Scholar
• Björkholm C, Monteggia LM. BDNF — a key transducer of antidepressant effects. Neuropharmacology. 2016;102:72–79. doi:10.1016/j.neuropharm.2015.10.03426519901
   PubMed Web of Science ®Google Scholar
• Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059–1077. doi:10.1007/s40262-016-0383-627028535
   PubMed Web of Science ®Google Scholar
• Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68(15):1178–1182. doi:10.1212/01.wnl.0000259085.61898.9e17420400
   PubMed Web of Science ®Google Scholar